NCT00788684 2025-02-20Safety Study of ABT-263 in Combination With Rituximab in Lymphoid CancersAbbViePhase 1 Completed29 enrolled
NCT01744626 2016-04-19Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCelgene CorporationPhase 1 Completed40 enrolled